← 홈

고형암 (전체)

791개 · ADC 1032 · Antibody 4683 · CGT 2713 · 다음 갱신 D-7 · 마지막 7월 21일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 791개
ADCBiologicstaleNEOK Bio, Inc.Phase 1

NEOK002 RDE (NEOK002 RDE)

Locally Advanced (Unresectable) or Metastatic Solid Tumors · Locally Advanced (Unresectable) or Metas

#LocallyAdvancedUnresectableorMet#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
CGTBiologicstaleHangzhou Cancer HospitalPhase 1

NK Cell adaptive transfer (NK Cell adaptive transfer)

Advanced Cancer; ADCC · Advanced Cancer

#AdvancedCancer#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 ACTIVE
CGTBiologicstaleGuangzhou Xiling Biotechnology …Phase 1

NK cell preparation (NK cell preparation)

Advanced Solid Tumors (Phase 1) · Advanced Solid Tumors (Phase 1)

#AdvancedSolidTumorsPhase1#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 1상태 RECRUITING
CGTBiologicstaleZhejiang UniversityPhase 1

NKG2D CAR NK and NKG2D CAR T cells (NKG2D CAR NK and NKG2D CAR T cells)

Patients With Advanced Solid Tumors With Liver Metastases Who Have Failed Standard Treatments · Patients With Advanced Solid Tumors With

#PatientsWithAdvancedSolidTumorsW#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 1상태 RECRUITING
CGTBiologicstaleZhejiang Provincial People's Ho…Phase 2

NKG2D CAR-NK with PD-1 Antibody (NKG2D CAR-NK with PD-1 Antibody)

Anaplastic Throid Carcinoma · PD-1

#PD-1#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
CGTBiologicstaleUniversity of ChicagoPhase 2

NY-ESO-1 TCR/ dnTGFβRII (NY-ESO-1 TCR/ dnTGFβRII)

Ovarian Cancer; Advanced Malignant Solid Tumor · Ovarian Cancer

#OvarianCancer#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
ADCBiologicstaleOncomatryx Biopharma S.L.Phase 1

Nab-paclitaxel + Gemcitabine (Nab-paclitaxel + Gemcitabine)

Pancreatic Adenocarcinoma Metastatic · Pancreatic Adenocarcinoma Metastatic

#PancreaticAdenocarcinomaMetastat#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
AntibodystaleWeill Medical College of Cornel…Phase 1

Naptumomab Estafenatox (Naptumomab Estafenatox)

Urothelial Carcinoma · Urothelial Carcinoma

#UrothelialCarcinoma#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 DISCONTINUED
CGTBiologicstalePACT Pharma, Inc.Phase 1

NeoTCR-P1 adoptive cell therapy (NeoTCR-P1 adoptive cell therapy)

Solid Tumor · Solid Tumor

#SolidTumor#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 1상태 DISCONTINUED
AntibodystaleSeoul National University Hospi…Preclinical

atezolizumab (Tecentriq, Neoadjuvant atezolizumab)

Urothelial Carcinoma · Urothelial Carcinoma

#UrothelialCarcinoma#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleThe Netherlands Cancer InstitutePhase 2

Neoadjuvant ipilimumab (Neoadjuvant ipilimumab)

Renal Cell Carcinoma · Renal Cell Carcinoma

#RenalCellCarcinoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleThe Netherlands Cancer InstitutePhase 2

nivolumab (Opdivo, Neoadjuvant nivolumab)

Renal Cell Carcinoma · Renal Cell Carcinoma

#RenalCellCarcinoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleThe Netherlands Cancer InstitutePhase 2

Neoadjuvant relatlimab (Neoadjuvant relatlimab)

Renal Cell Carcinoma · Renal Cell Carcinoma

#RenalCellCarcinoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
ADCBiologicstaleGilead SciencesPreclinical

ADC (Non-Investigational Antibody-Drug Conjugates, Non-Investigational Antibody-Drug Conjugates (ADC))

HER2-negative Breast Cancer; HER2 Negative Breast Carcinoma · HER2

#HER2#ADC#Preclinical#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 RECRUITING
CGTBiologicstaleThird Affiliated Hospital, Sun …Phase 1

Normal Dose NK cells ×4 times (Normal Dose NK cells ×4 times)

Hepatocellular Carcinoma · Hepatocellular Carcinoma

#HepatocellularCarcinoma#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 1상태 ACTIVE
CGTBiologicstaleThird Affiliated Hospital, Sun …Phase 1

Normal Dose NK cells ×8 times (Normal Dose NK cells ×8 times)

Hepatocellular Carcinoma · Hepatocellular Carcinoma

#HepatocellularCarcinoma#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 1상태 ACTIVE
ADCBiologicstaleOBI Pharma, IncPhase 2

OBI-902 (OBI-902)

Advanced Solid Tumor · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleOBI Pharma, IncPhase 2

OBI-992 (OBI-992)

Advanced Solid Tumor · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleOBI Pharma, IncPhase 2

OBI-999 (OBI-999)

Locally Advanced Solid Tumor · Locally Advanced Solid Tumor

#LocallyAdvancedSolidTumor#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
효능 ORR 0%임상시험 1상태 DISCONTINUED
ADCBiologicstaleOxford BioTherapeutics LtdPhase 1

OBT076, a CD205-directed antibody-drug conjugate (OBT076, a CD205-directed antibody-drug conjugate)

Solid Tumor · CD20

#CD20#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING

31 / 40 페이지

← 이전다음 →